Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -127.33% |
| Q3 2025 | 611.77% |
| Q2 2025 | 54.30% |
| Q1 2025 | -153.69% |
| Q4 2024 | 36.72% |
| Q3 2024 | -52.55% |
| Q2 2024 | 43.31% |
| Q1 2024 | 25.01% |
| Q4 2023 | 36.84% |
| Q3 2023 | -14.91% |
| Q2 2023 | 31.35% |
| Q1 2023 | -7.10% |
| Q4 2022 | 13.22% |
| Q3 2022 | -22.63% |
| Q2 2022 | -12.27% |
| Q1 2022 | 6.08% |
| Q4 2021 | 24.36% |
| Q3 2021 | 10.78% |
| Q2 2021 | -19.35% |
| Q1 2021 | -334.66% |
| Q4 2020 | 157.68% |
| Q3 2020 | -14.40% |
| Q2 2020 | 29.74% |
| Q1 2020 | -49.11% |
| Q4 2019 | -62.14% |
| Q3 2019 | 1.78% |
| Q2 2019 | -40.57% |
| Q1 2019 | -38.71% |
| Q4 2018 | -1.35% |
| Q3 2018 | -7.91% |
| Q2 2018 | -53.36% |
| Q1 2018 | -19.06% |
| Q4 2017 | -57.75% |
| Q3 2017 | 4.56% |
| Q2 2017 | -33.97% |
| Q1 2017 | -36.72% |
| Q4 2016 | 8.20% |
| Q3 2016 | -8.49% |
| Q2 2016 | 0.00% |
| Q1 2016 | 19.10% |